Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Affect lability? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Affect lability have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.0% of all adverse event reports for CYCLOPHOSPHAMIDE.

15
Reports of Affect lability with CYCLOPHOSPHAMIDE
0.0%
of all CYCLOPHOSPHAMIDE reports
0
Deaths
6
Hospitalizations

How Dangerous Is Affect lability From CYCLOPHOSPHAMIDE?

Of the 15 reports, 6 (40.0%) required hospitalization, and 6 (40.0%) were considered life-threatening.

Is Affect lability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Affect lability?

DULOXETINE (2,510) METFORMIN (291) AMLODIPINE (274) METHOTREXATE (266) ATORVASTATIN (259) IRBESARTAN (257) LEVOTHYROXINE (251) SITAGLIPTIN (244) ESOMEPRAZOLE (234) ASPIRIN (224)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Affect lability Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Affect lability Reports All Drugs Causing Affect lability CYCLOPHOSPHAMIDE Demographics